Zobrazeno 1 - 10
of 113
pro vyhledávání: '"Ming Tain Lai"'
Autor:
Peter S. Chang, Yi-Chun Chen, Wei-Kai Hua, Jeff C. Hsu, Jui-Cheng Tsai, Yi-Wun Huang, Yi-Hsin Kao, Pei-Hua Wu, Po-Nan Wang, Yi-Fang Chang, Ming-Chih Chang, Yu-Cheng Chang, Shiou-Ling Jian, Jiann-Shiun Lai, Ming-Tain Lai, Wei-Cheng Yang, Chia-Ning Shen, Kuo-Lan Karen Wen, Sareina Chiung-Yuan Wu
Publikováno v:
PLoS ONE, Vol 19, Iss 8 (2024)
Externí odkaz:
https://doaj.org/article/a24dce73854148dc9828f7489ea2bfaa
Autor:
Ming-Chen Yang, Chun-Chung Wang, Wei-Chien Tang, Kuan-Ming Chen, Chu-Ying Chen, Hsiao-Han Lin, Yin-Cheng Hsieh, Nan-Hsuan Wang, Yin-Chieh Kuo, Ping-Tzu Chu, Hsin-Yi Tung, Yi-Chen Wu, Juo-Ling Sun, Sheng-Yu Liu, Wan-Fen Li, Wei-Han Lee, Jiann-Shiun Lai, Michael Chang, Ming-Tain Lai
Publikováno v:
PLoS ONE, Vol 18, Iss 3, p e0283473 (2023)
SARS-CoV-2 pandemic has profound impacts on human life and global economy since the outbreak in 2019. With the new variants continue to emerge with greater immune escaping capability, the protectivity of the available vaccines is compromised. Therefo
Externí odkaz:
https://doaj.org/article/6fb17c9ac64c44429bdf1cbbdafd9f89
Autor:
Daniel M. Gorman, Ming-Tain Lai, Carolyn McHale, Meiqing Lu, Don Graham, Julie Strizki, Yanyan Zheng, Shirley Ma, Soha Moltagh, Marc Bailly, SuChun Hseih, Glareh Azadi, Yaoli Song, Fernando Ugarte, Romina Riener, Wendy Blumenschein, Daria Hazuda, Jeffery Nordstrom, Bonnie Howell
Publikováno v:
Journal of Virus Eradication, Vol 5, Iss , Pp 22- (2019)
Externí odkaz:
https://doaj.org/article/f2198540a84f48a28c4ad2e3cd169728
Autor:
Ming-Tain Lai, Cheng-Der Yu, Jiann-Shiun Lai, Nan-Hsuan Wang, Yueh-Chin Wu, Chi-Huan Lu, Hui-Wen Chang, Yu-Jung Chen, Teng-Yi Huang, I-Ju Chen, Chun-Chung Wang, Wan-Fen Li, Chi-Sheng Shia, Ming-Chen Yang
Supplementary Materials and Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bcba16014f579e89354c9b3b53f5503c
https://doi.org/10.1158/1535-7163.22522797
https://doi.org/10.1158/1535-7163.22522797
Autor:
Ming-Tain Lai, Cheng-Der Yu, Jiann-Shiun Lai, Nan-Hsuan Wang, Yueh-Chin Wu, Chi-Huan Lu, Hui-Wen Chang, Yu-Jung Chen, Teng-Yi Huang, I-Ju Chen, Chun-Chung Wang, Wan-Fen Li, Chi-Sheng Shia, Ming-Chen Yang
Supplementary Figures and Tables
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ec703d5b83c795ac018834b8be04b3f
https://doi.org/10.1158/1535-7163.22522800
https://doi.org/10.1158/1535-7163.22522800
Publikováno v:
Cancer Research. 83:5946-5946
Background: Globo H (GH) is highly expressed in a variety of epithelial tumors with a limited expression in normal tissues rendering it a novel therapeutic target. OBI-999 is an antibody drug conjugate (ADC) consisting of a GH-specific monoclonal ant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f11a391f62a059f742e00b7d6760c9d0
https://doi.org/10.1158/1538-7445.am2023-5946
https://doi.org/10.1158/1538-7445.am2023-5946
Publikováno v:
Cancer Research. 83:4084-4084
Background: Globo H (GH), a Globo-series glycosphingolipid (GSL), is highly expressed in epithelial tumors, such as colon, endometrial, gastric, pancreatic, lung, prostate, and breast cancers. Aberrant expression of Globo H has been reported to be as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::93576af8b7f212c84656f43c23825c73
https://doi.org/10.1158/1538-7445.am2023-4084
https://doi.org/10.1158/1538-7445.am2023-4084
Autor:
Tracy L. Diamond, Winnie Ngo, Min Xu, Shih Lin Goh, Silveria Rodriguez, Ming-Tain Lai, Ernest Asante-Appiah, Jay A. Grobler
Publikováno v:
Antimicrob Agents Chemother
Islatravir (ISL) is a nucleoside reverse transcriptase translocation inhibitor (NRTTI) that inhibits human immunodeficiency virus (HIV) reverse transcription by blocking reverse transcriptase (RT) translocation on the primer:template. ISL is being de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93972fb718323bf1419e15e05e1a3b9d
https://europepmc.org/articles/PMC9211433/
https://europepmc.org/articles/PMC9211433/
Autor:
Peter S. Chang, Yi-Chun Chen, Wei-Kai Hua, Jeff C. Hsu, Jui-Cheng Tsai, Yi-Wun Huang, Yi-Hsin Kao, Pei-Hua Wu, Yi-Fang Chang, Ming-Chih Chang, Yu-Cheng Chang, Shiou-Ling Jian, Jiann-Shiun Lai, Ming-Tain Lai, Wei-Cheng Yang, Chia-Ning Shen, Kuo-Lan Karen Wen, Sareina Chiung-Yuan Wu
BackgroundCD19-targeted chimeric antigen receptor therapies (CAR19) have driven a paradigm shift in the treatment of relapsed/refractory B-cell malignancies. However, >50% of CAR19-treated patients experienced progressive disease mainly due to antige
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::70c7124184947136f175986840868698
https://doi.org/10.1101/2022.05.03.490475
https://doi.org/10.1101/2022.05.03.490475
Autor:
Ming-Tain Lai, Meizhen Feng, Min Xu, Winnie Ngo, Tracy L. Diamond, Carey Hwang, Jay A. Grobler, Daria J. Hazuda, Ernest Asante-Appiah
Publikováno v:
Antimicrob Agents Chemother
Doravirine (DOR), a non-nucleoside reverse transcriptase inhibitor (NNRTI), was approved for treatment of HIV-1 infection in 2018. In the pivotal phase 3 trials, DRIVE-FORWARD and DRIVE-AHEAD, 7 out of 747 (0.9%) treatment-naive participants treated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bcbbe7a8bb197cfd2b944cf714b8939f
https://pubmed.ncbi.nlm.nih.gov/35491829
https://pubmed.ncbi.nlm.nih.gov/35491829